Business Context and Reporting Period
Company: Utah Medical Products, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 29, 2024
Reporting Period: The filing references financial information for the three and nine months ended September 30, 2024, and includes forward-looking statements for 2024 and beyond.
Key Financial Metrics
The provided text serves as a cover document referencing Exhibit 99.1 for detailed financial data. Consequently, specific numerical values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this filing text. The filing states that this information is furnished pursuant to Item 2.02 and is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Material Changes
The filing text does not explicitly detail material changes versus prior periods. It directs readers to the attached press release (Exhibit 99.1) for results of operations and financial condition comparisons.
Guidance, Outlook, and Risks
Outlook: The filing incorporates forward-looking statements relating to 2024 and beyond as presented in a press release dated October 29, 2024.
Risks and Contingencies: No specific risks or contingencies are detailed in the text of this 8-K. The document notes that the financial information is not subject to the liabilities of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (the press release) for specific revenue, profit, and cash flow figures for the three and nine months ended September 30, 2024.
- Verify the forward-looking statements regarding 2024 and beyond contained in the referenced press release.
- Confirm that the financial data is unaudited and furnished under Item 2.02, meaning it is not formally "filed" under Section 18 of the Exchange Act.
- Check for any subsequent filings that may provide updated liquidity or debt positions not detailed in this summary.